Gossamer Bio Inc (NASDAQ:GOSS) price on Thursday, March 20, fall -0.74% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.35.
A look at the stock’s price movement, the close in the last trading session was $1.36, moving within a range at $1.32 and $1.37. The beta value (5-Year monthly) was 1.863. Turning to its 52-week performance, $1.55 and $0.50 were the 52-week high and 52-week low respectively. Overall, GOSS moved -4.93% over the past month.
Gossamer Bio Inc’s market cap currently stands at around $306.75 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-12.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 19.89M, representing a -82.66% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GOSS is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
10 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 7 recommend GOSS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GOSS’s current price about 5.55% and 16.94% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.87, while 7-day volatility ratio is 8.99% and 10.79% in the 30-day chart. Further, Gossamer Bio Inc (GOSS) has a beta value of 1.80, and an average true range (ATR) of 0.12. Analysts have given the company’s stock an average 52-week price target of $4, forecast between a low of $2 and high of $5. Looking at the price targets, the low is -48.15% off current price level while to achieve the yearly target high, price needs to move -270.37%. Nonetheless, investors will most likely welcome a -196.3% jump to $4 which is the analysts’ median price.
If we refocus on Gossamer Bio Inc (NASDAQ:GOSS), historical trading data shows that trading volumes averaged 1.62 over the past 10 days and 1.39 million over the past 3 months. The company’s latest data on shares outstanding shows there are 226.60 million shares.
The 19.64% of Gossamer Bio Inc’s shares are in the hands of company insiders while institutional holders own 58.93% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.59 million on 2025-02-28, giving us a short ratio of 3.23. The data shows that as of 2025-02-28 short interest in Gossamer Bio Inc (GOSS) stood at 254.0 of shares outstanding, with shares short falling to 5.81 million registered in 2025-01-31. Current price change has pushed the stock 49.24% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GOSS stock continues to rise going into the next quarter.
